The central paradox is that rotavirus vaccines are given orally, which means they must replicate in the infant intestine to stimulate immunity. Live attenuated vaccine viruses are swallowed, infect cells lining the small intestine, and mimic a natural infection without causing disease. This replication triggers both antibodies and local T cell responses at the mucosal surface, the front line of defense against a virus that attacks the gut. Any factor that interferes with vaccine virus replication therefore blunts the immune response. In high-income countries, vaccine take is robust: most infants seroconvert, developing measurable antibody responses after two or three doses. In many parts of Africa and Asia, by contrast, the same or similar vaccine formulations induce protective responses in a substantially smaller fraction of recipients, leaving a large proportion of children vulnerable to severe disease despite being fully vaccinated.

One of the best-documented explanations involves maternal antibodies. Pregnant women transfer immunoglobulin G across the placenta, arming newborns with passive immunity against pathogens they have encountered. Mothers also pass antibodies to their infants through breast milk, particularly secretory immunoglobulin A, which coats the intestinal lining. These maternal antibodies can neutralize vaccine virus in the infant gut before it has a chance to infect enough cells to prime the immune system. The review highlights that this interference may be exacerbated in low- and middle-income countries for two reasons. First, women in high-transmission settings have experienced more natural rotavirus infections over their lifetimes, so they carry higher circulating and mucosal antibody levels to pass on. Second, breastfeeding practices differ: prolonged and exclusive breastfeeding, which carries many other benefits, means infants continue receiving antibody-rich milk throughout the vaccination window, sustaining the inhibitory pressure on oral vaccine replication.

The evidence for maternal antibody interference is not merely circumstantial. Studies have correlated higher titers of transplacentally acquired antibodies and breast milk antibody concentrations with reduced vaccine immunogenicity, and some trials have explored delaying vaccination or manipulating feeding around the time of dosing to see whether responses improve. The relationship is complex, because breast milk also contains other bioactive components, including antimicrobial proteins and factors that shape the developing gut microbiome, so the net effect of breastfeeding on vaccine performance is not uniformly negative. Nevertheless, the review argues that in settings where both maternal antibody levels and breastfeeding duration are high, passive immunity represents a significant and underappreciated barrier to successful oral vaccination, one that helps explain why infants in the highest-burden countries respond least well to the current vaccines.

Beyond maternal antibodies, the overall health of the infant gut emerges as a decisive factor. Malnutrition, widespread in many resource-limited regions, impairs the immune system in multiple ways, reducing the capacity of intestinal immune cells to respond to stimulation and compromising the structural integrity of the gut barrier. Environmental enteric dysfunction, a chronic inflammatory condition of the small intestine common among children in settings with poor sanitation and repeated microbial exposure, flattens the villi that absorb nutrients and alters the cellular landscape that vaccine viruses must infect. A gut in this state is a hostile environment for an attenuated live vaccine: inflammation accelerates the turnover of intestinal epithelial cells, shortening the window in which vaccine virus can replicate, and the damaged mucosa mounts aberrant immune responses that fail to generate durable protection against rotavirus.

The gut microbiome adds another layer of complexity. The trillions of microbes colonizing the infant intestine do not merely coexist with the immune system; they actively train it. Early-life microbial colonization influences the development of mucosal lymphoid tissue, the balance of inflammatory and regulatory responses, and even the expression of antiviral genes in epithelial cells. Disruption of this microbial community, through malnutrition, antibiotic exposure, recurrent infections or poor sanitation, can leave the gut immune system poorly calibrated for responding to an oral vaccine. The review emphasizes that the relative contributions of malnutrition, microbiome disruption and environmental enteric dysfunction vary by geography, so no single intervention will correct the problem everywhere. In one region, nutritional supplementation may be the dominant lever; in another, sanitation and microbial restoration may matter more.

Competition from other oral vaccines and concurrent enteric infections provides further interference, and both are more prevalent in resource-limited settings. The oral poliovirus vaccine, given on schedules that often overlap with rotavirus vaccination, replicates in the same intestinal niche and can interfere with rotavirus vaccine take, an interaction documented in trials where the two vaccines were co-administered. Meanwhile, infants in high-burden environments are frequently infected with other enteric pathogens, including bacteria, parasites and other viruses, at the very time they are being immunized. These co-infections can crowd out vaccine virus, provoke inflammatory responses that disrupt mucosal immunity, or redirect the immune system’s attention away from rotavirus. The cumulative effect is that an infant in a low-income setting may face a gauntlet of biological obstacles to oral vaccination that an infant in a wealthy country rarely encounters.

Host genetics introduces a less obvious but increasingly well-supported variable. Rotavirus entry into intestinal cells depends on histo-blood group antigens, carbohydrate structures on the cell surface whose synthesis is governed by fucosyltransferase genes. Different human populations carry different frequencies of polymorphisms in these genes, and these variants determine which histo-blood group antigens an individual’s gut expresses. Because particular rotavirus strains, and by extension particular vaccine strains, show preferences for certain antigen types, an infant’s genotype can influence how readily the vaccine virus infects intestinal cells and stimulates immunity. The review highlights that these genetic differences across populations further modulate vaccine immunogenicity, adding a layer of biological variation that cannot be addressed through delivery or nutrition alone and that may partly explain geographic patterns of vaccine failure.

A crucial theme running through the review is that none of these factors acts in isolation. Maternal antibodies, nutritional status, microbiome composition, environmental enteric dysfunction, co-infections, co-vaccinations and host genetics interact to shape the gut environment and collectively limit oral vaccine replication. A malnourished infant in a high-transmission setting may simultaneously face high maternal antibody levels, a dysbiotic microbiome, an inflamed intestine, competing enteric infections and a genotype less permissive to the vaccine strain. The result is a multiplicative, not merely additive, reduction in vaccine effectiveness. This systems-level view reframes the problem: rather than searching for a single silver bullet, researchers and public health programs must consider how multiple determinants converge in specific populations and design interventions accordingly.

The path forward, the authors argue, requires context-specific strategies that combine several approaches. Optimized vaccine scheduling, including adjustments to the timing and number of doses relative to breastfeeding patterns and co-vaccinations, could reduce interference in some settings. Nutritional interventions and microbiome-targeted therapies may restore the gut environment to a state more conducive to oral vaccine replication. Ultimately, however, the review points toward the development of novel vaccine platforms capable of overcoming the unique immunological challenges of low- and middle-income countries, whether through injectable formulations that bypass the gut’s inhibitory environment, engineered vaccine strains resistant to neutralization, or adjuvanted approaches that strengthen mucosal responses. Closing the rotavirus vaccine equity gap is not only a scientific challenge but a moral imperative, given that the children least protected by current vaccines are those at greatest risk of dying from the disease the vaccines were designed to prevent.

Subject of Research: Determinants of variable rotavirus vaccine effectiveness across global settings

Article Title: Why does rotavirus vaccine effectiveness vary around the globe?

Article References: Why does rotavirus vaccine effectiveness vary around the globe?. (n.d.). https://doi.org/10.1371/journal.ppat.1014670

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014670

Keywords: rotavirus, vaccine effectiveness, maternal antibodies, gut microbiome, environmental enteric dysfunction, malnutrition, oral poliovirus vaccine, histo-blood group antigens, fucosyltransferase, low- and middle-income countries, mucosal immunity, PLOS Pathogens

The methodology behind the analysis reflects the modern standards of evidence synthesis. The research team searched MEDLINE through PubMed, Embase, Scopus, and Web of Science from database inception to July 2026, casting a wide net for observational studies that evaluated laboratory-confirmed enteric infections against stunting outcomes in children. Nineteen studies passed the quality threshold for the qualitative synthesis, and fourteen contributed effect estimates to the quantitative meta-analysis. The authors followed the PRISMA 2020 reporting guidelines, pooled odds ratios using random-effects models, and assessed risk of bias with the Newcastle–Ottawa Scale. Certainty of evidence was judged using the GRADE framework, the same structured approach that underpins World Health Organization guideline development. This combination of transparent searching, formal bias assessment, and pre-specified subgroup analyses gives the review a methodological rigor that many entries in the stunting literature have lacked.

The headline number deserves unpacking. An odds ratio of 1.94 means that children with laboratory-confirmed enteric infections had roughly 94 percent higher odds of being stunted, defined as height-for-age more than two standard deviations below the reference median, compared with children without such infections. That is a substantial association in a field where effect estimates often hover close to unity. But the pooled figure came with an I-squared statistic of 85.6 percent, indicating that more than eight-tenths of the variability among studies reflected real differences between populations and methods rather than random noise. In practical terms, the pooled odds ratio describes an average of a highly heterogeneous body of evidence, and the authors were careful not to oversell it. Heterogeneity of this magnitude is common in observational meta-analyses of infection and nutrition, where study settings range from urban slums to rural highlands and diagnostic tools range from microscopy to multiplex PCR.

To probe that heterogeneity, the team conducted pre-specified subgroup analyses across pathogen domains: bacterial, viral, protozoal, helminthic, and non-specific parasitic infections. The most consequential finding of the review may be what did not emerge. Despite wide differences in the biology of these organisms, the associations with stunting were broadly comparable across domains, with no statistically significant differences between pathogen groups. Bacteria such as enteroaggregative Escherichia coli, viruses such as rotavirus, protozoa such as Giardia and Cryptosporidium, and soil-transmitted helminths all appeared to leave children at similar elevated risk of growth faltering. The authors interpret this convergent pattern as evidence that multiple enteric pathogens may impair child growth through shared biological pathways rather than through pathogen-specific mechanisms.

That interpretation aligns with two decades of research into environmental enteric dysfunction, a subclinical condition of the small intestine that has become a central hypothesis in child growth biology. Repeated exposure to fecal pathogens is thought to provoke chronic mucosal inflammation, villous atrophy, increased intestinal permeability, and malabsorption, collectively blunting the child’s ability to convert food into linear growth. Studies cited in the review, including the Environmental Enteric Dysfunction Biopsy Initiative and work linking the condition to carnitine deficiency and altered fatty acid oxidation, describe a gut that is chronically inflamed and metabolically compromised even in children who never present with overt diarrhea. Chronic inflammation also suppresses the growth hormone–insulin-like growth factor-1 axis, the endocrine engine of linear growth, providing a plausible mechanistic bridge from a fecal-contaminated environment to a stunted child.

Meta-regression added a second layer of insight by identifying participant age and adjustment status as significant sources of between-study heterogeneity. The association between enteric infection and stunting was strongest among children younger than two years, which the authors read as a signal about the first 1000 days of life, the window from conception through roughly the second birthday during which linear growth velocity is highest and the developing gut and immune system are most vulnerable to disruption. This timing matters for intervention design. A child whose gut is repeatedly infected during the period of most rapid growth may sustain deficits that nutritional supplementation later in childhood cannot fully reverse, echoing longitudinal findings from the MAL-ED birth cohort across eight low- and middle-income country sites, which documented that even asymptomatic enteropathogen infections measurably depressed linear growth.

The finding that statistical adjustment for confounders shaped the observed effect estimates is equally important for readers interpreting the evidence. Observational studies of infection and stunting must contend with a dense thicket of confounding: household wealth, maternal education, water and sanitation access, breastfeeding practices, and diet all influence both infection risk and growth. Studies that adjusted more comprehensively for these factors produced different effect estimates than those that did not, and the meta-regression captured this as a source of heterogeneity. The very low GRADE rating applied to the pooled evidence reflects these inherent limitations. Association is not causation, reverse causality remains possible, since malnourished children may be more susceptible to infection as well as more harmed by it, and the Review authors are explicit that their pooled estimate should guide hypothesis formation and intervention priority-setting rather than be read as a precise causal coefficient.

The geographical scope of the underlying studies, spanning Ethiopia, Bangladesh, Indonesia, Peru, Zambia, Madagascar, the Philippines, Zimbabwe, and other low- and middle-income settings, underscores that the stunting–infection relationship is concentrated where sanitation infrastructure is weakest. Several included studies examined the interaction between enteric infections and environmental enteric dysfunction directly, and others evaluated how water, sanitation, and hygiene interventions perform in children carrying different pathogen burdens. Collectively, this literature suggests that the classic nutrition-centric framing of stunting, in which food insecurity is treated as the dominant driver, captures only part of the story. A child can consume adequate calories and still fail to grow if a chronically inflamed gut cannot absorb them.

For policymakers, the practical implications of the review are captured in its stated impact summary: the findings support integrating infection prevention, sanitation, and nutritional interventions into child stunting reduction programs, rather than pursuing these strategies in silos. That means pairing supplementary feeding and dietary diversification with safe water, improved sanitation, deworming where helminth burden is high, and, where available, vaccination against enteric pathogens. The absence of differences between pathogen domains complicates any pathogen-by-pathogen targeting strategy and instead argues for broad environmental measures that reduce exposure to the fecal–oral pathway as a whole. The vulnerability of children under two further suggests that interventions should begin in pregnancy and infancy, when the marginal return on preventing gut disruption is highest.

The review, published on 26 September 2026 with the DOI 10.1038/s41390-026-05520-4, arrives at a moment when the global health community is assessing why stunting prevalence has declined more slowly than under-five mortality. By quantifying a roughly twofold elevation in stunting odds associated with enteric infections across bacterial, viral, protozoal, and helminthic domains, and by flagging the first 1000 days as the period of maximal vulnerability, it offers both a synthesis of a fragmented literature and a clear agenda for what must come next: longitudinal studies with molecular diagnostics, better confounder control, and intervention trials that test whether breaking the infection–inflammation cycle unlocks growth that nutrition alone cannot deliver. The evidence may be graded very low in certainty, but the direction of the signal, and the scale of the population at risk, give it a weight that few will ignore.

Subject of Research: The association between enteric infections across four pathogen domains and childhood stunting in low- and middle-income countries

Article Title: Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains

Article References: Pauzi, R. Y., Iqhrammullah, M., Ihtiaringtyas, S., Ilmi, A. N., Kumaratih, L. W., Yuliana, P. T., Aqila, R. A., & Raizma, E. Z. N. (2026). Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains. Pediatric Research. https://doi.org/10.1038/s41390-026-05520-4

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05520-4

Keywords: childhood stunting, enteric infections, meta-analysis, systematic review, environmental enteric dysfunction, gut microbiology, pediatric growth, first 1000 days, soil-transmitted helminths, water sanitation and hygiene, low- and middle-income countries, GRADE evidence